De Alrijne Zorggroep bestaat uit het Alrijne Ziekenhuis, met locaties in Leiden, Leiderdorp en Alphen aan den Rijn, en Verpleeghuis Leythenrode in Leiderdorp en Verpleeghuis Oudshoorn in Alphen aan den Rijn.

During the past decade, Rijnland Ziekenhuis conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rijnland Ziekenhuis" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Amsterdam UMC, location VUmc" with 2 trials sponsored, "Maastricht University Medical Center" with 2 trials sponsored, "Rijnstate Hospital" with 2 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rijnland Ziekenhuis" #1 collaborator was "Groene Hart Ziekenhuis" with 2 trials as a collaborator, "Medical Center Haaglanden" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator and "AO Research Fund" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Rijnland Ziekenhuis" are "Atrial Fibrillation" (3 trials), "Heart Failure" (2 trials), "AV Block" (1 trials), "Acute Kidney Injury" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Rijnland Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Rijnland Ziekenhuis" are "Drug" (6 trials), "Procedure" (6 trials), "Device" (5 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "46 hrs Holter ECG recording" (1 trials), "7-Day Holter monitor." (1 trials), "BCG vaccine" (1 trials), "CHOP regimen" (1 trials) and "Cephalozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rijnland Ziekenhuis" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rijnland Ziekenhuis". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Rijnland Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rijnland Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".